A Texas small business proprietor slammed the Biden administration and local officials on Friday, telling "The usa Experiences" that their managing of...
Entered 2021 with a Focus on Cancer Immunotherapy and Next-Generation Infectious Vaccines and a Strong Balance Sheet Conference Call Begins...
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional...
WATERTOWN, Mass.--(BUSINESS WIRE)--Mar 18, 2021--SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today...
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) reported financial results for the second quarter of fiscal 2021, ended Feb. 28, 2021, with...
- Year-end 2020 cash, cash equivalents and marketable securities of $326.5 million, with projected runway into the second half of...
Marseille, March 18, 2021 (GLOBE NEWSWIRE) --Lacutamab received PRIME designation from the European Medicines Agency in Sezary Syndrome; clinical development...
Cash position of €62 million at year-end provides runway until the end of H2 2022Enrolment of SENS-401 Phase 2 SSNHL...
Outlines 2021 product pipeline milestones for COVID-19, influenza A and norovirus antiviral programsEnds 2020 with cash exceeding $33 million and...
ImmunoPrecise and Genmab enter into a technology partnership targeting infectious diseaseImmunoPrecise and Litevax advance SARS-CoV-2 vaccine candidate for further pre-clinical...
CHARLOTTESVILLE, Va., March 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical...
– FOTIVDA® (tivozanib) Approved for Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma Following Two or More Prior...
- First patient for Phase 1/2 SUNRISE trial expected to be enrolled in early 2021-Translational preclinical data for sAAVy platform...
MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) – Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused...
- Many worth-driving milestones expected through 2021- Trappsol® Cyclo™ Niemann Choose Disorder Style C (NPC) scientific method on track to...
LONDON (AP) — Irish well being officers on Sunday advisable the non permanent suspension of the AstraZeneca vaccine just after...
Well-positioned to be a long-term supplier of raw material and critical elements to the modern-day infrastructure marketNear-term catalysts expected to...
– Phase 1/2 Trial for Lead Candidate CFT7455, a MonoDAC™ Degrader Targeting IKZF1/3 for the Treatment of Hematologic Malignancies, On...
